A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESAR, Luiz Antonio Machado e POPPI, Nilson Tavares. Diabetes e insuficiência coronária crônica. Diabetes e doença cardiovaculares. Tradução . Rio de Janeiro: Atheneu, 2023. . . Acesso em: 28 jun. 2024.
APA
Cesar, L. A. M., & Poppi, N. T. (2023). Diabetes e insuficiência coronária crônica. In Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu.
NLM
Cesar LAM, Poppi NT. Diabetes e insuficiência coronária crônica. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
Vancouver
Cesar LAM, Poppi NT. Diabetes e insuficiência coronária crônica. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENESTRETI, Paulo Rizzo e BARACIOLI, Luciano Moreira e NICOLAU, Jose Carlos. Evento coronariano agudo no paciente diabético. Diabetes e doença cardiovaculares. Tradução . Rio de Janeiro: Atheneu, 2023. . . Acesso em: 28 jun. 2024.
APA
Genestreti, P. R., Baracioli, L. M., & Nicolau, J. C. (2023). Evento coronariano agudo no paciente diabético. In Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu.
NLM
Genestreti PR, Baracioli LM, Nicolau JC. Evento coronariano agudo no paciente diabético. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
Vancouver
Genestreti PR, Baracioli LM, Nicolau JC. Evento coronariano agudo no paciente diabético. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANSUR, Antonio de Padua. Diabetes e doenças cardiovasculares na mulher. Diabetes e doença cardiovaculares. Tradução . Rio de Janeiro: Atheneu, 2023. . . Acesso em: 28 jun. 2024.
APA
Mansur, A. de P. (2023). Diabetes e doenças cardiovasculares na mulher. In Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu.
NLM
Mansur A de P. Diabetes e doenças cardiovasculares na mulher. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
Vancouver
Mansur A de P. Diabetes e doenças cardiovasculares na mulher. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2024 jun. 28 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOYOSHIMA, Marcos Tadashi Kakitani et al. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, v. 15, p. 1-14 art. 42, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13098-023-01007-y. Acesso em: 28 jun. 2024.
APA
Toyoshima, M. T. K., Santana, M. de F. M., Silva, A. R. M., Mello, G. B., Bezerra, D. P. S., Góes, M. F. S., et al. (2023). Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, 15, 1-14 art. 42. doi:10.1186/s13098-023-01007-y
NLM
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
Vancouver
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Remo H. M. et al. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Circulation, v. 145, n. 21, p. 1581-1591, 2022Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.121.058103. Acesso em: 28 jun. 2024.
APA
Furtado, R. H. M., Raz, I., Goodrich, E. L., Murphy, S. A., Bhatt, D. L., Leiter, L. A., et al. (2022). Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Circulation, 145( 21), 1581-1591. doi:10.1161/CIRCULATIONAHA.121.058103
NLM
Furtado RHM, Raz I, Goodrich EL, Murphy SA, Bhatt DL, Leiter LA, Mcguire DK, Wilding JPH, Aylward P, Dalby AJ, Nicolau JC. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial [Internet]. Circulation. 2022 ; 145( 21): 1581-1591.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.121.058103
Vancouver
Furtado RHM, Raz I, Goodrich EL, Murphy SA, Bhatt DL, Leiter LA, Mcguire DK, Wilding JPH, Aylward P, Dalby AJ, Nicolau JC. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial [Internet]. Circulation. 2022 ; 145( 21): 1581-1591.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.121.058103
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA-JUNIOR, Daniel F et al. Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure. Life sciences, v. 305, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.120757. Acesso em: 28 jun. 2024.
APA
Arruda-junior, D. F., Salles, T. A., Martins, F. L., Antonio, E. L., Tucci, P. J. F., Gowdak, L. H. W., et al. (2022). Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure. Life sciences, 305. doi:10.1016/j.lfs.2022.120757
NLM
Arruda-junior DF, Salles TA, Martins FL, Antonio EL, Tucci PJF, Gowdak LHW, Tavares CAM, Girardi ACC. Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure [Internet]. Life sciences. 2022 ; 305[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.lfs.2022.120757
Vancouver
Arruda-junior DF, Salles TA, Martins FL, Antonio EL, Tucci PJF, Gowdak LHW, Tavares CAM, Girardi ACC. Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure [Internet]. Life sciences. 2022 ; 305[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.lfs.2022.120757
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Camila Maciel de et al. Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: the Baependi Heart Study. PLOS ONE, v. 17, n. 6, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0267723. Acesso em: 28 jun. 2024.
APA
Oliveira, C. M. de, Pavani, J. L., Liu, C., Balcells, M., Capasso, R., Alvim, R. de O., et al. (2022). Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: the Baependi Heart Study. PLOS ONE, 17( 6). doi:10.1371/journal.pone.0267723
NLM
Oliveira CM de, Pavani JL, Liu C, Balcells M, Capasso R, Alvim R de O, Mourao-Junior CA, Krieger JE, Pereira AC. Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: the Baependi Heart Study [Internet]. PLOS ONE. 2022 ; 17( 6):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1371/journal.pone.0267723
Vancouver
Oliveira CM de, Pavani JL, Liu C, Balcells M, Capasso R, Alvim R de O, Mourao-Junior CA, Krieger JE, Pereira AC. Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: the Baependi Heart Study [Internet]. PLOS ONE. 2022 ; 17( 6):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1371/journal.pone.0267723
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES JÚNIOR, Flávio Araujo et al. Empagliflozin inhibits proximal Tubule NHE3 activity, preserves GFR, and restores Euvolemia in nondiabetic rats with induced heart failure. American Society of Nephrology. Journal, v. 32, n. 7, p. 1616-1629, 2021Tradução . . Disponível em: https://doi.org/10.1681/ASN.2020071029. Acesso em: 28 jun. 2024.
APA
Borges Júnior, F. A., Santos, D. S. dos, Santos, A. B. dos, Polidoro, J. Z., Wisnivesky, A. C. T., Crajoinas, R. de O., et al. (2021). Empagliflozin inhibits proximal Tubule NHE3 activity, preserves GFR, and restores Euvolemia in nondiabetic rats with induced heart failure. American Society of Nephrology. Journal, 32( 7), 1616-1629. doi:10.1681/ASN.2020071029
NLM
Borges Júnior FA, Santos DS dos, Santos AB dos, Polidoro JZ, Wisnivesky ACT, Crajoinas R de O, Antônio EL, Jensen L, Caramelli B, Malnic G, Tucci PJ, Girardi ACC. Empagliflozin inhibits proximal Tubule NHE3 activity, preserves GFR, and restores Euvolemia in nondiabetic rats with induced heart failure [Internet]. American Society of Nephrology. Journal. 2021 ; 32( 7): 1616-1629.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1681/ASN.2020071029
Vancouver
Borges Júnior FA, Santos DS dos, Santos AB dos, Polidoro JZ, Wisnivesky ACT, Crajoinas R de O, Antônio EL, Jensen L, Caramelli B, Malnic G, Tucci PJ, Girardi ACC. Empagliflozin inhibits proximal Tubule NHE3 activity, preserves GFR, and restores Euvolemia in nondiabetic rats with induced heart failure [Internet]. American Society of Nephrology. Journal. 2021 ; 32( 7): 1616-1629.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1681/ASN.2020071029
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRIE, Mark C et al. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes. Jama-journal of the american medical association, v. 323, n. 14, p. 1353-1368, 2020Tradução . . Disponível em: https://doi.org/10.1001/jama.2020.1906. Acesso em: 28 jun. 2024.
APA
Petrie, M. C., Verma, S., Docherty, K. F., Inzucchi, S. E., Anand, I., Belohlavek, J., et al. (2020). Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes. Jama-journal of the american medical association, 323( 14), 1353-1368. doi:10.1001/jama.2020.1906
NLM
Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, Belohlavek J, Boehm M, Chiang C-E, Chopra VK, Nicolau JC. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes [Internet]. Jama-journal of the american medical association. 2020 ; 323( 14): 1353-1368.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1001/jama.2020.1906
Vancouver
Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, Belohlavek J, Boehm M, Chiang C-E, Chopra VK, Nicolau JC. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes [Internet]. Jama-journal of the american medical association. 2020 ; 323( 14): 1353-1368.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1001/jama.2020.1906
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Eduardo Bello et al. Pharmacological therapy and cardiovascular risk reduction for type 2 diabetes. Revista da associacao medica brasileira, v. 66, n. 9, p. 1283-1288, 2020Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.66.9.1283. Acesso em: 28 jun. 2024.
APA
Martins, E. B., Lima, E. G., Pitta, F. G., Carvalho, L. N. S., Queiroz, T. D. de, & Serrano Júnior, C. V. (2020). Pharmacological therapy and cardiovascular risk reduction for type 2 diabetes. Revista da associacao medica brasileira, 66( 9), 1283-1288. doi:10.1590/1806-9282.66.9.1283
NLM
Martins EB, Lima EG, Pitta FG, Carvalho LNS, Queiroz TD de, Serrano Júnior CV. Pharmacological therapy and cardiovascular risk reduction for type 2 diabetes [Internet]. Revista da associacao medica brasileira. 2020 ; 66( 9): 1283-1288.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1590/1806-9282.66.9.1283
Vancouver
Martins EB, Lima EG, Pitta FG, Carvalho LNS, Queiroz TD de, Serrano Júnior CV. Pharmacological therapy and cardiovascular risk reduction for type 2 diabetes [Internet]. Revista da associacao medica brasileira. 2020 ; 66( 9): 1283-1288.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1590/1806-9282.66.9.1283
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Camila Maciel de et al. Relationship between marital status and incidence of type 2 diabetes mellitus in a Brazilian rural population: The Baependi Heart Study. PLOS ONE, v. 15, n. 8, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0236869. Acesso em: 28 jun. 2024.
APA
Oliveira, C. M. de, Tureck, L. V., Alvares, D., Liu, C., Horimoto, A. R. V. R., Balcells, M., et al. (2020). Relationship between marital status and incidence of type 2 diabetes mellitus in a Brazilian rural population: The Baependi Heart Study. PLOS ONE, 15( 8). doi:10.1371/journal.pone.0236869
NLM
Oliveira CM de, Tureck LV, Alvares D, Liu C, Horimoto ARVR, Balcells M, Alvim R de O, Krieger JE, Pereira AC. Relationship between marital status and incidence of type 2 diabetes mellitus in a Brazilian rural population: The Baependi Heart Study [Internet]. PLOS ONE. 2020 ; 15( 8):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1371/journal.pone.0236869
Vancouver
Oliveira CM de, Tureck LV, Alvares D, Liu C, Horimoto ARVR, Balcells M, Alvim R de O, Krieger JE, Pereira AC. Relationship between marital status and incidence of type 2 diabetes mellitus in a Brazilian rural population: The Baependi Heart Study [Internet]. PLOS ONE. 2020 ; 15( 8):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1371/journal.pone.0236869
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCHI, Francesco et al. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. Journal of the american heart association, v. 8, n. 6, 2019Tradução . . Disponível em: https://doi.org/10.1161/JAHA.118.011139. Acesso em: 28 jun. 2024.
APA
Franchi, F., James, S. K., Lakic, T. G., Budaj, A. J., Cornel, J. H., Katus, H. A., et al. (2019). Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. Journal of the american heart association, 8( 6). doi:10.1161/JAHA.118.011139
NLM
Franchi F, James SK, Lakic TG, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Nicolau JC. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial [Internet]. Journal of the american heart association. 2019 ; 8( 6):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1161/JAHA.118.011139
Vancouver
Franchi F, James SK, Lakic TG, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Nicolau JC. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial [Internet]. Journal of the american heart association. 2019 ; 8( 6):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1161/JAHA.118.011139
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAY, Kausik K et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet diabetes & endocrinology, v. 7, n. 8, p. 618-628, 2019Tradução . . Disponível em: https://doi.org/10.1016/S2213-8587(19)30158-5. Acesso em: 28 jun. 2024.
APA
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-dinet, M., Bhatt, D. L., Bittner, V. A., et al. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet diabetes & endocrinology, 7( 8), 618-628. doi:10.1016/S2213-8587(19)30158-5
NLM
Ray KK, Colhoun HM, Szarek M, Baccara-dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Nicolau JC. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial [Internet]. Lancet diabetes & endocrinology. 2019 ; 7( 8): 618-628.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/S2213-8587(19)30158-5
Vancouver
Ray KK, Colhoun HM, Szarek M, Baccara-dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Nicolau JC. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial [Internet]. Lancet diabetes & endocrinology. 2019 ; 7( 8): 618-628.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/S2213-8587(19)30158-5
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEG, P. Gabriel et al. Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, v. 381, n. 14, p. 1309-1320, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1908077. Acesso em: 28 jun. 2024.
APA
Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., et al. (2019). Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, 381( 14), 1309-1320. doi:10.1056/NEJMoa1908077
NLM
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1056/NEJMoa1908077
Vancouver
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1056/NEJMoa1908077
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Lucas C et al. Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome. Canadian journal of cardiology, v. 35, n. 8, p. 993-1001, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2019.03.010. Acesso em: 28 jun. 2024.
APA
Godoy, L. C., Lawler, P. R., Farkouh, M. E., Hersen, B., Nicolau, J. C., & Rao, V. (2019). Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome. Canadian journal of cardiology, 35( 8), 993-1001. doi:10.1016/j.cjca.2019.03.010
NLM
Godoy LC, Lawler PR, Farkouh ME, Hersen B, Nicolau JC, Rao V. Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome [Internet]. Canadian journal of cardiology. 2019 ; 35( 8): 993-1001.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.cjca.2019.03.010
Vancouver
Godoy LC, Lawler PR, Farkouh ME, Hersen B, Nicolau JC, Rao V. Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome [Internet]. Canadian journal of cardiology. 2019 ; 35( 8): 993-1001.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.cjca.2019.03.010
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATT, Deepak L et al. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical cardiology, v. 42, n. 5, p. 498-505, 2019Tradução . . Disponível em: https://doi.org/10.1002/clc.23164. Acesso em: 28 jun. 2024.
APA
Bhatt, D. L., Fox, K., Harrington, R. A., Leiter, L. A., Mehta, S. R., Simon, T., et al. (2019). Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical cardiology, 42( 5), 498-505. doi:10.1002/clc.23164
NLM
Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstrale W, Nicolau JC. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study [Internet]. Clinical cardiology. 2019 ; 42( 5): 498-505.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1002/clc.23164
Vancouver
Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstrale W, Nicolau JC. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study [Internet]. Clinical cardiology. 2019 ; 42( 5): 498-505.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1002/clc.23164
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUEB, Thiago e RAMIRES, José Antônio Franchini e KALIL FILHO, Roberto. Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial [Carta]. Diabetology & metabolic syndrome. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13098-018-0320-y. Acesso em: 28 jun. 2024. , 2018
APA
Hueb, T., Ramires, J. A. F., & Kalil Filho, R. (2018). Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial [Carta]. Diabetology & metabolic syndrome. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13098-018-0320-y
NLM
Hueb T, Ramires JAF, Kalil Filho R. Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial [Carta] [Internet]. Diabetology & metabolic syndrome. 2018 ; 10[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13098-018-0320-y
Vancouver
Hueb T, Ramires JAF, Kalil Filho R. Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial [Carta] [Internet]. Diabetology & metabolic syndrome. 2018 ; 10[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13098-018-0320-y
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVERETT, Brendan M. et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, v. 71, n. 21, p. 2392-2401, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.03.002. Acesso em: 28 jun. 2024.
APA
Everett, B. M., Nicolau, J. C., DONATH, M. Y., PRADHAN, A. D., THUREN, T., PAIS, P., et al. (2018). Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, 71( 21), 2392-2401. doi:10.1016/j.jacc.2018.03.002
NLM
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Vancouver
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Andressa Heimbecher e CARAMELLI, Bruno. Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study. International journal of obesity, v. 42, n. 5, p. 953-963, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41366-018-0105-2. Acesso em: 28 jun. 2024.
APA
Soares, A. H., & Caramelli, B. (2018). Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study. International journal of obesity, 42( 5), 953-963. doi:10.1038/s41366-018-0105-2
NLM
Soares AH, Caramelli B. Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study [Internet]. International journal of obesity. 2018 ; 42( 5): 953-963.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1038/s41366-018-0105-2
Vancouver
Soares AH, Caramelli B. Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study [Internet]. International journal of obesity. 2018 ; 42( 5): 953-963.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1038/s41366-018-0105-2
